Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study - Wikidata - wikimedia - TriplyDB

Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study

Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study

http://www.wikidata.org/entity/Q36126617

about

Integrating palliative care into the trajectory of cancer care Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.Reply to minimal clinically important difference and Edmonton Symptom Assessment Scale Personalized symptom goals and response in patients with advanced cancer.Vertebral Augmentation Involving Vertebroplasty or Kyphoplasty for Cancer-Related Vertebral Compression Fractures: A Systematic Review Effects of a transitional palliative care model on patients with end-stage heart failure: a randomised controlled trial Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial.Fatigue and Quality of Life Outcomes of Palliative Care Consultation: A Prospective, Observational Study in a Tertiary Cancer Center.Development of Palliative Care in China: A Tale of Three Cities.Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.Integrative Oncology Outpatient Consultations: Long-Term Effects on Patient-Reported Symptoms and Quality of Life.Early palliative care for adults with advanced cancer.The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.Evaluation of the Appropriate Washout Period Following Fan Therapy for Dyspnea in Patients With Advanced Cancer: A Pilot Study.Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.The Frailty Phenotype and Palliative Care Needs of Older Survivors of Critical Illness.The effects of oncology massage on symptom self-report for cancer patients and their caregivers.Single Institute Experience With Methylphenidate and American Ginseng in Cancer-Related Fatigue.End-of-Life Care Matters: Palliative Cancer Care Results in Better Care and Lower Costs.Quality of life and symptom burden in patients with breast cancer treated with mastectomy and lumpectomy.Thyroid cancer patients receiving an interdisciplinary team-based care approach (ITCA-ThyCa) appear to display better outcomes: Program evaluation results indicating a need for further integrated care and support.Factors Associated with Attrition in a Multicenter Longitudinal Observational Study of Patients with Advanced Cancer.Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care.Adolescent-young adults (AYA) with cancer seeking integrative oncology consultations: demographics, characteristics, and self-reported outcomes.Quality of life (QOL) and symptom burden (SB) in patients with breast cancer.Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.Impact of outpatient palliative care (PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan.Characteristics and outcomes of patients with advanced cancer evaluated by a palliative care team at an emergency center. A retrospective study.The Edmonton Symptom Assessment Scale remains useful for depression screening.The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium.Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study.Predictors of responses to corticosteroids for anorexia in advanced cancer patients: a multicenter prospective observational study.Outpatient acupuncture effects on patient self-reported symptoms in oncology care: a retrospective analysis Symptom Burden and Palliative Referral Disparities in an Ambulatory South Texas Cancer Center

P2860

Q26776348-F5816758-685B-44D3-A2BF-BEF28673DEF7 Q36522629-55CE2025-6309-4465-97F5-2A81D824093D Q36688917-AA1F995D-C401-4DD1-B8A5-AAAB43444084 Q36918198-3EAEE5B8-43E1-4FBC-B52D-CBF9C7918EE4 Q36994303-76BEC15E-A45F-49A5-9DF7-865FE67B4AD9 Q37085669-F210EFFA-23AF-4960-804E-17A3BA47193F Q37120940-C0BEB838-7B31-4801-83C5-2240F356405C Q37353538-49C7802B-F703-4A51-93B9-B040B87AA76A Q38369499-64474DAF-BC65-4D25-8001-8481B1618530 Q38603148-B821AD87-182D-497C-94D5-322A1F405192 Q38642008-DAEB3ACD-96B2-40A4-A546-DE68D158C76B Q38730886-9AABD341-CB06-47ED-B93F-30C1B8ECC489 Q38775737-D323C599-F9C0-40E8-A8B3-E9A2F85B6F9F Q38806656-5F2FC249-CB7B-465E-BAC1-02BD9165E548 Q38807604-A3EE0CF3-09BB-40C2-8A99-398AC9EE844E Q38927263-3C7589E4-FCDC-4BCF-AC47-7C843948F9BF Q39153541-B2A320A2-1843-4784-AA72-123321FDEEE9 Q39181568-DDAA930C-AB68-4913-A484-159FF4049C12 Q39185434-04404BFB-44DD-469F-AB21-E8F3678BD702 Q40327074-3CB7E915-26CC-489D-84F9-75087F5B4933 Q47409651-A7D1DA43-5E9D-4AE0-A36A-1AFDBB8294AC Q47444474-0299CE35-1A68-4795-8BC7-184B19BE1F4A Q47568021-AC2E87D1-2578-4CCA-9E94-E462C82B1D26 Q47586307-F1A07D51-235E-4508-BCA6-55770E8FB148 Q47651148-B0650291-54D7-4E6F-A25F-2DF9AD4415A7 Q47803312-81CD8BB4-519F-4BDD-95B9-83E22825D3D8 Q47818673-61626D9D-93FF-4BDD-9918-5539EB0D0916 Q47916422-3359B348-F94B-4CE6-A4DC-C80805DF2BF6 Q48045802-15368A25-5C90-4016-A09D-3B5E22075BF5 Q51749020-061F2FEB-FF3D-4461-B6D4-76687C570CCD Q53547912-8BE13D73-F785-446E-BA4F-5CBAAEE365D2 Q53580809-7AB7AAAD-EE48-4F16-A358-1B68958B8A89 Q57493782-37815FF2-1F28-4405-81A2-0161C11046AC Q58122175-4B0860A4-70CF-4636-9E9A-5F7AF12F4746

P2860

Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study

http://www.wikidata.org/entity/Q36126617

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Minimal clinically important d ...... prospective, multicenter study

@ast

Minimal clinically important d ...... prospective, multicenter study

@en

type

label

Minimal clinically important d ...... prospective, multicenter study

@ast

Minimal clinically important d ...... prospective, multicenter study

@en

prefLabel

Minimal clinically important d ...... prospective, multicenter study

@ast

Minimal clinically important d ...... prospective, multicenter study

@en

P1433

Q36126617-0DF778B1-5B44-4CCC-9C11-40A98D3630E9

P1476

Q36126617-FA50CCB0-0952-42AC-BED5-53E3D9D3FFD5

P2093

Q36126617-2554F0B5-6AF8-46AC-994F-43B550EC5C5A

Q36126617-40F5C7F7-0842-44F6-9FA5-25DB8FA06C6F

Q36126617-42D69C6E-84BA-4725-870B-CE6EFFBC7048

Q36126617-4549844E-D09A-405C-B98B-08E58FB8DBE4

Q36126617-5862A306-CE45-4252-848E-60249A06991B

Q36126617-5B624147-152E-44F1-9E40-51AE19AC8A37

Q36126617-7C9769F9-43BA-49FB-AA01-B6EB0AE324F4

Q36126617-9F77EA43-F1AF-47FE-B7FD-C7DDCDD95309

Q36126617-A50CD96B-8A19-4B82-AF08-AF1D1EE34CCF

P2860

Q36126617-07B59802-5745-4055-A319-264602F292E9

Q36126617-1471EEAA-BA2D-40F4-8A21-8701B7B17DBD

Q36126617-192B0E83-D7C8-4E79-B333-072F0FE81675

Q36126617-1E453E14-B2E2-4802-AC68-EE4821693219

Q36126617-2208A815-7333-431F-89A1-15AA6837AE6B

Q36126617-275541F8-F6B4-49DE-B1C5-9088B3C4308C

Q36126617-2CC01A1E-3963-4237-9D4C-197B14073349

Q36126617-35B9DA57-44B8-40DE-86E4-E8857CD3134B

Q36126617-4900E059-E0CD-47EB-B528-DE2F9AB7139A

Q36126617-54A6429E-D933-49F3-B465-363130402ACB

P304

Q36126617-AD2D0312-72B8-4EA4-AAA8-E368DC32E60E

P31

Q36126617-1DA4A08D-776D-47F9-8465-3A6689D68F45

P356

Q36126617-5C7DA9B0-44D8-496C-927E-5A5613D83261

P407

Q36126617-7ABD0FEF-9B94-435D-B609-F58126CD0631

P433

Q36126617-1BC5953C-9959-4B53-B195-CD905757BCD4

P478

Q36126617-D2A802E3-15E6-496C-9C14-2B0B017E005F

P50

Q36126617-2D558BA4-17AF-4CB3-A604-662783AF196B

P577

Q36126617-D6833875-C22E-4A36-A2E4-20776B0DCB60

P698

Q36126617-6D0610F8-732A-46CE-9322-B5383FD42F96

P921

Q36126617-5AB77710-9513-4FE2-ACFB-11C7436A2863

P932

Q36126617-452560F4-A757-4F77-A5E4-AB68761124DF

P356

P1433

P1476

Minimal clinically important d ...... prospective, multicenter study

@en

P2093

Carlos Eduardo Paiva

http://www.w3.org/2001/XMLSchema#string

David Hui

http://www.w3.org/2001/XMLSchema#string

Jung Hun Kang

http://www.w3.org/2001/XMLSchema#string

Jung Hye Kwon

http://www.w3.org/2001/XMLSchema#string

Mary Ann Muckaden

http://www.w3.org/2001/XMLSchema#string

Minjeong Park

http://www.w3.org/2001/XMLSchema#string

Omar Shamieh

http://www.w3.org/2001/XMLSchema#string

Pedro Emilio Perez-Cruz

http://www.w3.org/2001/XMLSchema#string

Sriram Yennu

http://www.w3.org/2001/XMLSchema#string

P2860

The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991--2006)

The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients

Detecting alcoholism. The CAGE questionnaire

The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.

A personalized approach to assessing and managing pain in patients with cancer

Identifying meaningful intra-individual change standards for health-related quality of life measures.

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Measurement of health status. Ascertaining the minimal clinically important difference.

Understanding the minimum clinically important difference: a review of concepts and methods.

Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients

P304

3027-3035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.29437

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26059846

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4595042

http://www.w3.org/2001/XMLSchema#string